01/20/23 4:40 PMNasdaq : GTH Market Forecasts for Immuno-Oncology Diagnostics 2023: Sector Represents a Revolution in Cancer TherapyThe "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com' s offering. Diagnostics, companion diagnostics, is driving the success of Immuno- oncology Therapeutics. An entire new segment of the diagnostics industry is...RHEA-AIneutral
01/19/23 12:00 PMNasdaq : GTH, TRIB covid-19COVID-19 Pandemic Emphasized the Importance of In Vitro Diagnostics, More than $127 Billion Worth Market Opportunity in the IVD Market - AriztonAccording to Arizton's latest research report, the i n-vitro diagnostics market will grow at a CAGR of 3.3% from 2022-2028. In recent years, IVD diagnostics has been one of the biggest industries that observed several product launches. In 2022, North America accounted for the largest share of 40% of the global IVD market. The patient population with high...RHEA-AIneutral
01/19/23 10:45 AMNasdaq : GTH Global Immuno-Oncology Diagnostics Market Report 2023-2028: Diagnostic Companies and Instrumentation Suppliers are Jockeying for Position in a New Approach to Conquering CancerThe "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates" report has been added to ResearchAndMarkets.com' s offering. Diagnostics, companion diagnostics, is driving the success of Immuno- oncology Therapeutics. An entire new segment of the diagnostics industry is being created and its not a small segment either.RHEA-AIpositive
01/18/23 7:00 AMNasdaq : GTH Genetron Health Regains Compliance With Nasdaq Minimum Bid Price RequirementGenetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnosticsRHEA-AIneutral
11/07/22 6:00 AMNasdaq : GTH Genetron Health Announces Receipt of Notification from NasdaqGenetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnosticsRHEA-AIneutral
10/19/22 9:30 AMNasdaq : BNR, GTH Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 46% p.a., Reaching $8.6B by 2027 – Market Report by DeciBio Consulting LLCAccording to a comprehensive market report authored by DeciBio Consulting LLC,“ Oncology Liquid Biopsy Market Report 2022- 2027,” the global oncology liquid biopsy market, driven by growth in new applications– primarily minimum residual disease testing, serial monitoring, and early cancer detection– is predicted to reach $8.6 B by 2027.. This second edition of...RHEA-AIneutral
10/12/22 6:00 AMNasdaq : GTH earningsGenetron Health Reports Unaudited Second Quarter 2022 Financial ResultsGenetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnosticsRHEA-AInegative
09/02/22 7:00 AMNasdaq : GTH managementGenetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special CommitteeGenetron Holdings Limited (“ Genetron Health ” or the “ Company ”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnosticsRHEA-AIneutral
08/22/22 6:00 AMNasdaq : GTH acquisitionGenetron Health Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the CompanyGenetron Holdings Limited (“ Genetron Health ” or the “ Company ”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnosticsRHEA-AIneutral
06/16/22 9:44 AMNasdaq : GTH conferencesGenetron Health to Participate in the Goldman Sachs Healthcare Corporate DayGenetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnosticsRHEA-AIneutral